A shadow economy for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share comparison photos, injection guides and assertions of next-day British shipping. Sellers market the substance there before directing buyers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Experts Express Concerns
However, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the UK is worrisome and could lead to individuals injecting substances of unknown origin.
Some experts stated the demand for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.
Service Reaction and Content Elimination
According to the social media company, the platform has taken down violative material and banned related hashtags and query recommendations. The company stated it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.
Online Trading Activities
Investigations also found communities with up to nine thousand members marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, filled with images of weight loss, positive reviews and step-by-step guides for mixing or administering at home.
Within moments of joining one community, a seller shared contact information, where the majority of transactions occur. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.
Item Information and Costs
Inside these communities, posts display dark colored packages with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service stated it actively monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these online products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.
Her team has previously seen individuals injured by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to possibly significant health risks”.
